QTTB Overview

Company Profile

Related stocks

CBIO • United States

Crescent Biopharma, Inc.

14.91 USD

553.86M USD 1Y +17.1%

ALT • United States

Altimmune, Inc.

2.61 USD

507.69M USD 1Y -33.8%

CLYM • United States

Climb Bio, Inc.

11 USD

631.8M USD 1Y +503.3%

SGP • United States

SpyGlass Pharma, Inc.

24.92 USD

833.52M USD

NVCT • United States

Nuvectis Pharma, Inc.

21.12 USD

689.44M USD 1Y +223.1%

DRUG.CN • United States

BrightMindsBio

77.1 CAD

533.55M USD 1Y -10.3%

JBIO • United States

Jade Biosciences, Inc.

14.39 USD

915.17M USD 1Y +55.8%

ODTX • United States

Odyssey Therapeutics, Inc.

19 USD

913.11M USD

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

Region

Sector

Industry

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

131.1% p.a.

Max Drawdown (5Y)

-98.8%

Sharpe Ratio (5Y)

-0.33

Beta Factor

-0.11

Size Class

Micro Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Elevated Short-Term Volatility: 3Y volatility (151.3%) is noticeably higher than the 5Y average (131.1%).

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (131.1% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -99.8% in the extended horizon.